Inventus Capital Ltd. is a multi-industry, private equity company with operations in several countries. Established in 2011 by David Aiello, Inventus holds majority stakes in all its portfolio companies. The firm has made diverse investments, including in 3rd party logistics services (3PL) in Latin America, medical interventions, repurposing old drugs for new therapeutic applications through multinational academic cooperation, and commercial exploitation. Additionally, it has invested in financial services for major corporate entities in Canada and tailored background investigations, investment diligence related to recruitment, financial investment, and deep contextual research.
Inventus Capital's global reach and broad investment portfolio reflect its strategic positioning in various sectors. With its headquarter in Israel, the company has demonstrated a commitment to international growth and diversification. As a result, it presents an enticing opportunity for venture capitalists seeking to invest in a wide range of industries across different geographies.
